We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Medtronic
MDT
$107B
| $43.6M | 0.1% |
560,510
-1,205,190
| -68% | -$97.7M |
|
|
227
CALL
Johnson & Johnson
JNJ
$635B
| $43.2M | 0.1% |
244,400
+15,800
| +7% | +$2.73M |
|
228
Shake Shack
SHAK
$2.3B
| $42.8M | 0.1% |
1,029,880
+889,714
| +635% | +$43.3M |
|
229
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $42.5M | 0.1% |
723,000
-142,300
| -16% | -$8.76M |
|
230
Dollar Tree
DLTR
$23.1B
| $42.3M | 0.1% |
298,763
+91,002
| +44% | +$13.5M |
|
231
Devon Energy
DVN
$51.9B
| $42.2M | 0.09% |
+685,449
| New | +$46.7M |
|
232
Constellium
CSTM
$3.96B
| $41.8M | 0.09% |
3,532,790
-470,073
| -12% | -$5.49M |
|
|
233
PUT
Amazon
AMZN
$2.5T
| $41.5M | 0.09% |
494,000
+325,300
| +193% | +$32.1M |
|
|
GTLS
234
DELISTED
Chart Industries
GTLS
| $41.5M | 0.09% |
359,778
+352,931
| +5,155% | +$56.7M |
|
235
Revolve Group
RVLV
$1.79B
| $40.9M | 0.09% |
1,838,351
+482,785
| +36% | +$11.6M |
|
236
Prudential Financial
PRU
$41.7B
| $40.6M | 0.09% |
408,383
+388,212
| +1,925% | +$39.3M |
|
237
Telefônica Brasil
VIV
$22.4B
| $40.6M | 0.09% |
5,672,238
+5,138,597
| +963% | +$38.4M |
|
238
Martin Marietta Materials
MLM
$33.6B
| $40.3M | 0.09% |
119,384
+29,020
| +32% | +$9.9M |
|
239
CALL
Apple
AAPL
$4.89T
| $40.3M | 0.09% |
309,800
-149,800
| -33% | -$21.4M |
|
240
International Paper
IP
$22.3B
| $40M | 0.09% |
1,155,679
+981,905
| +565% | +$34M |
|
241
United Rentals
URI
$71.1B
| $39.8M | 0.09% |
111,872
-271,780
| -71% | -$89.3M |
|
242
BJs Wholesale Club
BJ
$11.9B
| $39.7M | 0.09% |
599,611
-1,513,675
| -72% | -$110M |
|
243
Tandem Diabetes Care
TNDM
$1.17B
| $39.6M | 0.09% |
+881,307
| New | +$39.9M |
|
244
Graphic Packaging
GPK
$3.26B
| $39.3M | 0.09% |
1,768,302
-1,786,912
| -50% | -$39.3M |
|
|
JOYY
245
JOYY Inc
JOYY
$3.73B
| $39.2M | 0.09% |
1,241,842
+576,992
| +87% | +$16.7M |
|
246
Maravai LifeSciences
MRVI
$997M
| $39.2M | 0.09% |
2,740,696
+663,660
| +32% | +$10.4M |
|
247
PUT
Netflix
NFLX
$292B
| $39.2M | 0.09% |
1,329,000
-241,000
| -15% | -$6.76M |
|
|
AXNX
248
DELISTED
Axonics, Inc. Common Stock
AXNX
| $39.2M | 0.09% |
626,135
-207,946
| -25% | -$13.8M |
|
|
249
CALL
Netflix
NFLX
$292B
| $38.8M | 0.09% |
1,316,000
+140,000
| +12% | +$3.93M |
|
250
Kimberly-Clark
KMB
$36.4B
| $38.7M | 0.09% |
285,310
-93,391
| -25% | -$11.9M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.